about
A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicityHuman chorionic gonadotropin in pregnancy and maternal risk of breast cancer.Human papillomavirus and Papanicolaou tests to screen for cervical cancer.Human immunoglobulin G levels of viruses and associated glioma riskAntibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis.Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden2-[4,5-Difluoro-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid, an antiviral compound with activity against acyclovir-resistant isolates of herpes simplex virus types 1 and 2.Human chorionic gonadotropin and alpha-fetoprotein concentrations in pregnancy and maternal risk of breast cancer: a nested case-control study.Maternal smoking during pregnancy and testicular cancer in the sons: a nested case-control study and a meta-analysis.Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer.Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks.Chlamydia trachomatis infection and persistence of human papillomavirus.Multivalent HSA conjugates of 3'-sialyllactose are potent inhibitors of adenoviral cell attachment and infection.Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers.Synthesis, biological evaluation, and structure-activity relationships of 2-[2-(benzoylamino)benzoylamino]benzoic acid analogues as inhibitors of adenovirus replication.CD46 is a cellular receptor for all species B adenoviruses except types 3 and 7.Adenovirus type 37 uses sialic acid as a cellular receptor on Chang C cells.Small-molecule screening using a whole-cell viral replication reporter gene assay identifies 2-{[2-(benzoylamino)benzoyl]amino}-benzoic acid as a novel antiadenoviral compound
P50
Q28727030-2F8243FB-4F2E-495E-9CAD-99E2A3B532F4Q34235316-9736A572-A234-4049-8B31-0A1509B419E6Q34702284-1C2D7AA5-E51E-4FF8-801A-21C4981BD356Q35136924-ACEEF503-DF51-4B03-8764-8F879FB83D2FQ35620298-03949A7B-6281-41EA-8BE5-E942F594AA71Q35620360-5C02623B-0A90-4E89-BDD9-A1CE9625D5BFQ36364125-3B15ED63-9873-40A9-B063-73C8A244E999Q36984874-C7BB9801-17C1-416D-A65F-41C9D5E6FE17Q37397374-5CCDDEF7-B48C-465A-A1E4-02D2D712C1DDQ37850050-B9563123-C68E-47FE-96B5-FD25B57A48E7Q37855991-AB3E347B-91BB-4F54-926B-A0EC2002780BQ37865331-5AC6D22F-EA69-4A8D-8DDA-D7FDA74F57C8Q38331292-BFF4D2F8-65D5-4FFC-9B6E-F352B0608147Q38397934-69D84684-CD90-4278-B815-B98B5BBE1339Q39389605-6E6788A3-9F59-4BED-A3A0-E62F98CB1F95Q39612847-6DDD57D1-96B9-4CA4-9487-A4CB93124084Q39686608-2FD92C91-B659-44E7-ACF8-E3EC22698FB5Q39687396-0E367978-E981-40D2-8BEC-18F8AFDC5B08
P50
description
onderzoeker
@nl
name
Göran Wadell
@ast
Göran Wadell
@en
Göran Wadell
@nl
Göran Wadell
@sl
type
label
Göran Wadell
@ast
Göran Wadell
@en
Göran Wadell
@nl
Göran Wadell
@sl
prefLabel
Göran Wadell
@ast
Göran Wadell
@en
Göran Wadell
@nl
Göran Wadell
@sl